Data as of Nov 26
| +0.23 / +0.42%|
The 2 analysts offering 12-month price forecasts for ANI Pharmaceuticals Inc have a median target of 61.50, with a high estimate of 65.00 and a low estimate of 58.00. The median estimate represents a +10.99% increase from the last price of 55.41.
The current consensus among 2 polled investment analysts is to Buy stock in ANI Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.